Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionCapital Insight Partners, Llc
Latest Disclosed Ownership13,873 shares
Latest Disclosed Value $ 1,183,288
Capital Insight Partners, Llc reports 64.50% decrease in ownership of EW / Edwards Lifesciences Corporation

On February 17, 2026 - Capital Insight Partners, Llc filed a 13F-HR form disclosing ownership of 13,873 shares of Edwards Lifesciences Corporation (MX:EW) valued at $1,183,288 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 14, 2025 disclosing 39,076 shares of Edwards Lifesciences Corporation. This represents a change in shares of -64.50% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 13,873 -25,203 -64.50 1,183 -61.06 0.2504
2025-10-14 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 39,076 -10,231 -20.75 3,039 -21.21 0.5031
2025-07-17 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 49,307 -8,108 -14.12 3,856 -7.33 0.6702
2025-04-30 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 57,415 -5,077 -8.12 4,161 -10.05 0.7261
2025-01-24 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 62,492 2,164 3.59 4,626 16.20 0.7997
2024-10-09 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 60,328 4,290 7.66 3,981 -23.09 0.6968
2024-07-24 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 56,038 -459 -0.81 5,176 -4.11 0.9769
2024-04-16 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 56,497 6,602 13.23 5,399 41.90 1.0088
2024-01-24 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 49,895 1,589 3.29 3,804 13.69 0.7781
2023-10-30 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 48,306 2,546 5.56 3,347 -22.47 0.7602
2023-07-24 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 45,760 -163 -0.35 4,317 13.61 0.9656
2023-04-28 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 45,923 891 1.98 3,799 13.10 0.8931
2023-02-07 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 45,032 1,267 2.90 3,360 -7.11 0.8713
2022-10-20 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 43,765 607 1.41 3,616 -11.89 0.9743
2022-07-20 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 43,158 314 0.73 4,104 -18.64 0.9582
2022-04-21 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 42,844 2,572 6.39 5,044 -3.32 1.0290
2022-01-20 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 40,272 846 2.15 5,217 16.89 1.0619
2021-10-13 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 39,426 -16 -0.04 4,463 9.25 0.9700
2021-08-02 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 39,442 1,007 2.62 4,085 27.06 0.9227
2021-04-20 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 38,435 1,813 4.95 3,215 -3.77 0.7811
2021-02-02 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 36,622 588 1.63 3,341 16.17 0.8408
2020-11-04 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 36,034 33 0.09 2,876 15.59 0.8086
2020-07-15 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 36,001 24,224 205.69 2,488 12.02 0.7848
2020-04-14 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,777 1,130 10.61 2,221 -10.59 1.1734
2020-01-27 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 10,647 -156 -1.44 2,484 4.55 1.1411
2019-10-09 2019-09-30 13F Edwards Lifesciences Corporati COM 28176E108 10,803 -250 -2.26 2,376 16.36 2.0755
2019-07-09 2019-06-30 13F Edwards Lifesciences Corporati COM 28176E108 11,053 43 0.39 2,042 -3.08 1.7744
2019-04-04 2019-03-31 13F Edwards Lifesciences Corporati COM 28176E108 11,010 53 0.48 2,107 25.57 1.9037
2019-01-03 2018-12-31 13F Edwards Lifesciences Corporati COM 28176E108 10,957 48 0.44 1,678 -11.64 1.7323
2018-10-03 2018-09-30 13F Edwards Lifesciences Corporati COM 28176E108 10,909 10,909 1,899 1.6706
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.